Assignee
ZYMEDI CO LTD
KR·3 granted patents·3 pending applications·1 citations·filing 2018–2023
Top patents by PatentIndex Score
6 records- 0169US11378572B2Therapeutic agent for immune cell migration-caused disease and method for screening sameZYMEDI CO LTD·Filed 2019·Granted Jul 5, 2022·1 cites·5 claims
- 0262US2026041745A1Novel crs fragment peptide with immunopotentiating activity, and use thereofZYMEDI CO LTD·Filed 2023·Application pending·0 cites
- 0355US2025108102A1Novel fragmented crs peptide exhibiting immune enhancement activity, and use thereofZYMEDI CO LTD·Filed 2021·Application pending·0 cites
- 0444US2022049016A1Antibody for Specifically Binding to Lysyl-tRNA Synthetase N-Terminal Domain Exposed to Extracellular MembraneZYMEDI CO LTD·Filed 2019·Application pending·0 cites
- 0542US11965038B2Pharmaceutical composition comprising antibody binding specifically to lysyl-tRNA synthetase N-terminus as effective ingredient for preventing or treating immune cell migration-related diseaseZYMEDI CO LTD·Filed 2018·Granted Apr 23, 2024·0 cites·12 claims
- 0634US11685791B2Antibody binding specifically to N-terminal region of lysyl-tRNA synthetase exposed on cell membraneZYMEDI CO LTD·Filed 2018·Granted Jun 27, 2023·0 cites·8 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →